NCT07019610View on ClinicalTrials.gov

Chlorhexidine Caps for CLABSI Prevention in Hemodialysis: a Pilot Randomized Controlled Trial

NANot yet recruitingINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

August 31, 2025

Primary Completion Date

December 31, 2027

Study Completion Date

February 29, 2028

Conditions
Vascular Access ComplicationDevice Related InfectionDevice Related SepsisCatheter InfectionCatheter ComplicationsCatheter-Related InfectionsCatheter Related ComplicationsHemodialysis Catheter InfectionHemodialysis Catheter-associated InfectionHemodialysis Complication
Interventions
DEVICE

ClearGuard HD

The ClearGuard HD end cap is a male luer lock end cap that incorporates an antimicrobial treatment (Chlorhexidine) on its surface designed to reduce microbial colonisation within a haemodialysis catheter hub.

DEVICE

B Braun Combi-stopper

Standard practice caps used within the Metro North Kidney Health Service

Trial Locations (1)

4029

Royal Brisbane and Women's Hospital, Herston

All Listed Sponsors
collaborator

Royal Brisbane and Women's Hospital

OTHER_GOV

lead

The University of Queensland

OTHER